STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
Maastricht Radiation Oncology
LigaChem Biosciences, Inc.
Washington University School of Medicine
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Columbia University
Thomas Jefferson University
Thomas Jefferson University
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Aminex Therapeutics, Inc.
The New York Proton Center
Washington University School of Medicine
Cedars-Sinai Medical Center
Washington University School of Medicine
Mayo Clinic
P-Cure
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Dana-Farber Cancer Institute
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
University of California, San Francisco
Hospices Civils de Lyon
Albert Einstein College of Medicine
Massachusetts General Hospital
University Hospital Tuebingen
Tocagen Inc.
Icahn School of Medicine at Mount Sinai
IGF Oncology, LLC
University of Illinois at Chicago
Stanford University
Medical University of South Carolina
SWOG Cancer Research Network
Dana-Farber Cancer Institute
University of Miami
University of Miami
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
University of Arizona
National Cancer Institute (NCI)
Cancer Trials Ireland
GE Healthcare
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center